Anebulo Pharmaceuticals (ANEB) Interest Expenses (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) recorded Interest Expenses of $17,439 in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 82.6% from $100,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Interest Expenses (2021 - 2025) Analysis & Trends
On a TTM basis, Anebulo Pharmaceuticals' Interest Expenses came in at $315,485 as of Dec 31, 2025, down 14.3% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $400,000, up 100.0% from FY2024.
- Annual Interest Expenses has a five-year compound annual growth rate of 215.2% (FY2020 to FY2025).
- Across earlier fiscal years, Interest Expenses came in at $200,000 in FY2024 and $11,767 in FY2021 (+815.0%).
- Quarterly Interest Expenses has ranged from $3,701 in fiscal Q3 2021 to $245,182 in fiscal Q3 2025 over the past five years.
- On a year-over-year basis, Interest Expenses has declined for three consecutive quarters, with growth averaging 58.5% over the last five quarters.
- Per Business Quant, the preceding three fiscal quarters came in at $17,439 (Q1 2026), $35,425 (Q4 2025) and $245,182 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 17,439.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 17,439.00 |
| Sep 30, 2025 | 17,439.00 |
| Jun 30, 2025 | 35,425.00 |
| Mar 31, 2025 | 245,182.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 108,466.00 |
| Mar 31, 2024 | 59,696.00 |
| Dec 31, 2023 | 31,838.00 |
| Mar 31, 2021 | 3,701.00 |
API Access
Anebulo Pharmaceuticals Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();